| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YEXMP.2018.05.003 |
| P698 | PubMed publication ID | 29775572 |
| P50 | author | Thomas Schachner | Q42836131 |
| P2093 | author name string | Christina Maria Steger | |
| Ralf Joachim Rieker | |||
| Johannes Bonatti | |||
| Nikolaos Bonaros | |||
| P2860 | cites work | Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors | Q71934600 |
| Collagen-induced thrombus formation in flowing nonanticoagulated human blood from habitual smokers and nonsmoking patients with severe peripheral atherosclerotic disease | Q72235612 | ||
| c-myc in vasculoproliferative disease | Q72455494 | ||
| Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action | Q73965653 | ||
| Saphenous vein graft protection: effects of c-myc antisense | Q74123452 | ||
| Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro | Q74351464 | ||
| Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation | Q74546242 | ||
| Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenti | Q77480637 | ||
| Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts | Q77943304 | ||
| Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2 | Q81472578 | ||
| Matrix metalloproteinases and angiogenesis | Q81864212 | ||
| Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? | Q28582075 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| Substance-specific importance of EGFR for vascular smooth muscle cells motility in primary culture. | Q30315400 | ||
| The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation | Q33667278 | ||
| The role of c-myc in cellular growth control | Q33667324 | ||
| Regulation of proliferation, survival and apoptosis by members of the TNF superfamily | Q34269354 | ||
| Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion | Q35107957 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Regulation of matrix biology by matrix metalloproteinases | Q35885655 | ||
| Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | Q35993294 | ||
| Apoptotic signaling by c-MYC. | Q37310199 | ||
| Roles of TGFbeta in metastasis | Q37339711 | ||
| Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts | Q37365179 | ||
| Evidence for a role of collagen synthesis in arterial smooth muscle cell migration | Q37381419 | ||
| Oncogenes, growth factors, and signal transduction | Q38715382 | ||
| MYC regulates the antitumor immune response through CD47 and PD-L1 | Q38787131 | ||
| Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells | Q39017565 | ||
| Hypoxia inducible factor-1 alpha induction by tumour necrosis factor-alpha, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes | Q39801207 | ||
| Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. | Q42473074 | ||
| Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein | Q43526519 | ||
| Surgical injury of rat arteries: genetic control of the remodelling process. | Q44079605 | ||
| Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. | Q44157813 | ||
| Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells | Q46591146 | ||
| Control of cell proliferation by Myc. | Q47721327 | ||
| c-MYC oncoprotein production in experimental vein graft intimal hyperplasia | Q48520397 | ||
| Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells. | Q51128749 | ||
| Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model. | Q53248034 | ||
| Evidence for Oxidative Activation of c-Myc–Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits | Q58863672 | ||
| c-Myc Antisense Oligonucleotides Preserve Smooth Muscle Differentiation and Reduce Negative Remodelling following Rat Carotid Arteriotomy | Q63343303 | ||
| Intimal proliferation in an organ culture of human internal mammary artery | Q67472465 | ||
| Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor | Q70865414 | ||
| An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro | Q71113729 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2018-05-15 | |
| P1433 | published in | Experimental and Molecular Pathology | Q15767470 |
| P1476 | title | Gene therapy with antisense oligonucleotides silencing c-myc reduces neointima formation and vessel wall thickness in a mouse model of vein graft disease | |
| P478 | volume | 105 |
Search more.